Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Western Blot Products
  4. General Western Blot Reagents
  5. 502706852

Abcam WY 14643, PPARalpha Agonist, >99% Purity, Solid, 50 mg

Catalog No. 502706852
Encompass_Preferred
Change view
Click to view available options
Quantity:
50 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
50-270-6852 50 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 50-270-6852 Supplier Abcam Supplier No. AB14114250MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

Description

Selective PPARα agonist that reduces inflammatory responses in vitro and in vivo.

  • Selective PPARα agonist: EC50 values are 0.63, 32 and >100 μM at PPARα, PPARγ and PPARδ receptors respectively.
  • Purity: >99%
  • Molecular weight: 323.8 g/mol
  • Form: Solid
  • Anti-inflammatory: Able to reduce inflammatory responses in vivo and in vitro.
  • CAS Number: 50892-23-4
  • Storage: Store at Ambient.

The product is subject to the following: Abcam Restricted Use Statement

Specifications

Target Molecule PPARα (PPARγ, PPARδ)
Shipping Condition Ambient
Content And Storage Store at ambient temperature.
Buffer 100% ((4-Chloro-6-(2,3-xylidino)-2-pyrimidinyl)thio)acetic acid
Form Solid
Formulation 100% ((4-Chloro-6-(2,3-xylidino)-2-pyrimidinyl)thio)acetic acid
Quantity 50 mg
For Use With (Application) PPARalpha agonist, inflammatory response modulation
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.